896PPredictive radiomics signature for treatment response to nivolumab in patients (pts) with advanced renal cell carcinoma (RCC). (23rd October 2018) - Sim, H-W; Stundzia, A; Pierre, S; Metser, U; O'Malley, M; Elimova, E; Sridhar, S S; Hansen, A